Breakthrough Initiative Addresses Shortage of Personal Protective Equipment for Nation’s Healthcare Workers in Wake of COVID-19 Pandemic

Accelerator, Blog, Cardiology & Cardiothoracic, Design & Development, GCMI, GI, neurology, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

Research Collaboration to Allow Manufacturers to 3D Print Thousands of Face Shields in the Coming Weeks    Atlanta, GA – March 24, 2020 – Global Center for Medical Innovation (GCMI), the Southeast’s first and only comprehensive medical device innovation center, today announced a collaboration that addresses the severe shortage of personal protective equipment (PPE) for…

The most expensive study is one you have to repeat. 10 things to know before you start your GLP study.

Blog, Cardiology & Cardiothoracic, GCMI, GI, neurology, News, orthopedic, Physician Innovators, Preclinical CRO Excellence, Regenerative Medicine, spine, T3

Good laboratory practice (GLP) studies are an essential component to medical product development and regulatory submissions. They are highly rigorous, are conducted in compliance with a  legally bound code of federal regulations (21 CFR Part 58) and should be conducted by qualified scientists and staff of an accredited contract research organization (CRO). They are also…

Looking to engage an Industry Leading Preclinical CRO? Connect with T3 Labs at TCT 2019!

Blog, Cardiology & Cardiothoracic, Conferences, T3

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 25-29, 2019 in San Francisco, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year, and our booth number is A2118.

Commercializing Research to Reengineer Healthcare as We Know It

Blog, Cardiology & Cardiothoracic, Design & Development, GCMI, Preclinical CRO Excellence

  GCMI’s 2018 year end review and 2019 look ahead Thanks to our staff, customers, sponsors and fellow industry, academic and philanthropic visionaries, GCMI has tangibly advanced our mission of accelerating the development, testing, training and commercialization of innovative medical products that improve quality based outcomes and delivery of healthcare for patients. 2018 Highlights Leading…

Evaluating or Ready to Engage an Industry Leading Preclinical CRO? Connect with T3 Labs at TCT 2018, Booth 334!

Blog, Cardiology & Cardiothoracic, Conferences, Event, GCMI, News, T3

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 21-25, 2018 in San Diego, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year. Our booth number is 334.  We’re excited to spend…

HRS 2018 Insights: Read about future technologies and how T3 Labs can be your partner in emerging EP research.

Blog, Cardiology & Cardiothoracic, Conferences, Preclinical CRO Excellence, T3

As the leading annual electrophysiology event, HRS will always bring the latest advancements in pacing, ablation and mapping to the society’s annual meeting. The 2018 edition was no exception and included a few variations on atrial fibrillation (AF) ablations. Catheter Ablation vs/ Antiarrhythmic Drug Therapy The big news from the show was the dissemination of…

Learning about the latest transcatheter cardiovascular innovation at TCT 2017 – Connect with T3 Labs booth #6001

Cardiology & Cardiothoracic, News, T3

Starting Sunday, October 29, industry leaders in transcatheter cardiovascular innovation will convene in Denver, Colorado for TCT 2017. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center for transcatheter innovation and education. The goal? As always, to improve patient care.…

Improving patient outcomes through research and medtech innovation with confidence: Dr. Robert Matheny’s T3 narrative

Blog, Cardiology & Cardiothoracic, Design & Development, Regenerative Medicine, T3

Having a facility like T3 to test novel and breakthrough applications’ ability to save lives is crucial for battling diseases and disorders. Dr. Matheny and the original team of T3 recognized the need and saw to it that it was met. The change in landscape for innovators was born from desperation and a desire to…

Aortic & mitral valves galore plus bioresorbable scaffold results: T3 Labs’ insights from TCT 2016

Blog, Cardiology & Cardiothoracic, T3

The Cardiovascular Research Foundation’s annual TCT conference serves as the premier cardiovascular event of the year: delivering the latest clinical and preclinical updates on a wide spectrum of transcatheter therapies and the 2016 edition was no exception. In addition to catching up with existing and prospective sponsors and FDA regulators, here are a few of…